A project called ACT-CHIK has been launched to accelerate the development of a chikungunya vaccine in Africa. The initiative is part of broader efforts to address viral threats, with some outlets reporting on the launch of large-scale studies and commitments to advance vaccine development in the region. However, the current status and timeline for a chikungunya vaccine are unclear, with some outlets discussing the challenges and complexities of vaccine development.